The role of drug efflux pumps in acute myeloid leukemia

被引:75
作者
Van Der Kolk, DM [1 ]
De Vries, EGE [1 ]
Müller, M [1 ]
Vellenga, E [1 ]
机构
[1] Univ Groningen Hosp, Dept Internal Med, Div Hematol, NL-9713 GZ Groningen, Netherlands
关键词
AML; P-gp; MRP1; BCRP; efflux pumps; MDR;
D O I
10.1080/10428190290016773
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A major problem in the treatment of patients with acute myeloid leukemia (AXIL) is the occurrence of resistance to structurally and functionally unrelated chemotherapeutic agents, called multidrug resistance (MDR). One of the known MDR mechanisms is the overexpression of adenosine triphosphate, (ATP)-dependent efflux pumps. Permeability-glycoprotein (P-gp), the best characterized of the human drug efflux pumps, has been shown to be associated with poor treatment outcome in AML patients. Besides P-gp, in addition the multidrug resistance protein 1 (MRP1) appeared to contribute to the observed resistance in AML. Alternative transporter proteins, such as the MRP1 homologues MRP2, MRP3, MRP5 and MRP6, and the breast cancer resistance protein (BCRP), have been shown to be expressed at variable levels in AML patient cells. The latter proteins have been described to confer resistance to chemotherapeutic agents, such as daunorubicin, mitoxantrone, etoposide and 6-mercaptopurine, which are generally used in the treatment of AML patients; however, they have not yet proven to play a role in drug resistance in AML. The present review gives an overview of the current knowledge concerning these drug transporters, with a focus on the role of the transporter proteins in AML.
引用
收藏
页码:685 / 701
页数:17
相关论文
共 233 条
[71]  
HEUVELEIBRINK MM, 2001, BLOOD, V97, P3605
[72]   FLIP-FLOP - THE TRANSMEMBRANE TRANSLOCATION OF LIPIDS [J].
HIGGINS, CF .
CELL, 1994, 79 (03) :393-395
[73]  
HIPFNER DR, 1994, CANCER RES, V54, P5788
[74]   Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3) [J].
Hirohashi, T ;
Suzuki, H ;
Sugiyama, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (21) :15181-15185
[75]   Functional polymorphisms of the human multidrug-resistance gene:: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo [J].
Hoffmeyer, S ;
Burk, O ;
von Richter, O ;
Arnold, HP ;
Brockmöller, J ;
Johne, A ;
Cascorbi, I ;
Gerloff, T ;
Roots, I ;
Eichelbaum, M ;
Brinkmann, U .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3473-3478
[76]   Differential cytotoxicity of clinically important camptothecin derivatives in P-glycoprotein overexpressing cell lines [J].
Hoki, Y ;
Fujimori, A ;
Pommier, Y .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (05) :433-438
[77]  
HOMOLYA L, 1993, J BIOL CHEM, V268, P21493
[78]  
Honjo Y, 2001, CANCER RES, V61, P6635
[79]   Potent interaction of flavopiridol with MRP1 [J].
Hooijberg, JH ;
Broxterman, HJ ;
Scheffer, GL ;
Vrasdonk, C ;
Heijn, M ;
de Jong, MC ;
Scheper, RJ ;
Lankelma, J ;
Pinedo, HM .
BRITISH JOURNAL OF CANCER, 1999, 81 (02) :269-276
[80]  
Hooijberg JH, 1999, CANCER RES, V59, P2532